Project Grant HT94252510859
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $7.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency awarded a $319,204 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) to conduct research on "Advanced Brain Age Modeling in Multiple Sclerosis: Toward a Prognostic Biomarker for Personalized Medicine." The award, which runs from August 15, 2024, to August 14, 2026, is part of the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research initiatives aimed at...
- The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
- The Defense Health Agency awarded a $633,750 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) on August 1, 2025 under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research on the "INTERPLAY BETWEEN SENSORY NEURONS AND NK CELLS DURING BREAST CANCER METASTATIC DORMANCY" with a performance period ending on July 31, 2028. As a leading academic medical center, ISMMS has demonstrated extensive capabilities...
- The U.S. Defense Health Agency awarded a $1,751,468.00 Project Grant to the Weill Medical College of Cornell University on September 1, 2025 through the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research to investigate the "circulating antibody repertoire and blood-brain-barrier impairment" that may explain neuropsychiatric symptoms associated with "invisible" brain injuries. As a prestigious academic medical...
- The Defense Health Agency awarded the Icahn School of Medicine at Mount Sinai a $3,300,817.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will leverage personalized stem cell therapy to overcome airway reconstruction challenges. The research will be conducted in New York, NY and is expected to be completed by May 31, 2029. The Icahn School of Medicine at Mount Sinai is a prominent academic medical center and research institution known for...
- The U.S. Defense Health Agency awarded a $2,175,896 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from June 1, 2025 to June 30, 2029, supports advanced biomedical research to investigate metabolites, metabolic pathways, and the risk of Crohn's disease. As a leading academic medical center and research institution, ISMMS will leverage its expertise in areas such...
- The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
- This $949,181 federal Project Grant award was provided by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research by the Icahn School of Medicine at Mount Sinai to investigate the association between cortical lesions and physical/cognitive disability in multiple sclerosis using novel, clinically feasible MRI methods. The research aims to advance the understanding and treatment of multiple sclerosis, a...
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,209,600.00 Project Grant to Albert Einstein College of Medicine in Bronx, New York under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will support a project titled "VALIDATION OF BIOMARKERS OF POST-TRAUMATIC SEIZURES IN AN OPTIMIZED MODEL OF TRAUMATIC BRAIN INJURY" with a completion date of June 30, 2026. Through this funding, Albert Einstein College of...
- The U.S. Defense Health Agency has awarded a $2,028,000.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY. The grant, awarded on April 1, 2025, supports research to identify epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. As a leading academic medical research institution, ISMMS has demonstrated extensive capabilities in conducting...